Genome editing and gene regulation in industrial eukaryotic biotechnology

CRISPR-Cas9 is proving to be an efficient and customizable alternative to other existing genome editing tools. Since the CRISPR-Cas9 system itself is capable of cutting DNA strands, CRISPRs do not need to be paired with separate cleaving enzymes as other tools do. They can also easily be matched with tailor-made “guide” RNA (gRNA) sequences designed to lead them to their DNA targets. Tens of thousands of such gRNA sequences have already been created and are available to the research community. CRISPR-Cas9 can also be used to target multiple genes simultaneously, which is another advantage that sets it apart from other gene-editing tools

    Related Conference of Genome editing and gene regulation in industrial eukaryotic biotechnology

    July 21-22, 2025

    18th World Congress on Stem Cell Research

    Barcelona, Spain
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Genome editing and gene regulation in industrial eukaryotic biotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in